For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has approved a new pain medication that could change how we manage acute pain.

The FDA has approved suzetrigine (Journavx), a new non-opioid oral drug for acute pain in adults – the first new class of non-opioid pain medicine approved in over 20 years.